Some doctors may be unaware on the regional/distant metastasis-free survival gain explained within a subsequent publication, in which the regional and distant metastatic failure level was decreased by practically 50 percent in the focal Increase arm [2]. Further ongoing trials could also corroborate the FLAME outcomes, encouraging adoption.Followin… Read More